PROTOCOLOS CLÍNICOS E DIRETRIZES TERAPÊUTICAS

Protocolos Clínicos e Diretrizes Terapêuticas 12 R eferências Bibliográficas 1. Drachman DB. Myasthenia gravis. N Engl J Med. 1994;330(25):1797-810. 2. Scherer K, Bedlack RS, Simel DL. Does this patient have myasthenia gravis? JAMA. 2005;293(15):1906-14. 3. Skeie GO, Apostolski S, Evoli A, Gilhus NE, Hart IK, Harms L, et al. Guidelines for the treatment of autoimmune neuromuscular transmission disorders. Eur J Neurol. 2006;13(7):691-9. 4. AAEM Quality Assurance Committee. American Association of Electrodiagnostic Medicine. Literature review of the usefulness of repetitive nerve stimulation and single fiber EMG in the electrodiagnostic evaluation of patients with suspected myasthenia gravis or Lambert-Eaton myasthenic syndrome. Muscle Nerve. 2001;24(9):1239-47. 5. Amato AA, Russel JA. Disorders of neuromuscular transmission. In: Amato AA, Russel JA, editors. Neuromuscular disorders. New York: McGraw Hill; 2008. p. 457-528. 6. Meriggioli MN, Sanders DB. Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity. Lancet Neurol. 2009;8(5):475-90. 7. Vincent A, Palace J, Hilton-Jones D. Myasthenia gravis. Lancet. 2001;357(9274):2122-28. 8. Wirtz PW, Sotodeh M, Nijnuis M, Van Doorn PA, Van Engelen BG, Hintzen RQ, et al. Diference in distribution of muscle weakness between myasthenia gravis and the Lambert-Eaton myastenic syndrome. J Neurol Neurosurg Psychiatry. 2002;73(6):766-8. 9. Oh SJ, Eslami N, Nishihira T, Sarala PK, Kuba T, Elmore RS. Electrophysiological and clinical correlation in myasthenia gravis. Ann Neurol. 1982;12(4):348-54. 10. Osserman KE, Genkins G. Studies in myasthenia gravis: a review of a twenty-year experience in over 1200 patients. Mt Sinai J Med. 1971;38(6):497-537. 11. Gilchrist JM, Massey JM, Sanders DB. Single fiber emg and repetitive stymulation of the same muscle in myasthenia gravis. Muscle Nerve. 1994;17(2):171-5. 12. Heitmiller RF. Myasthenia gravis: clinical features, pathogenesis, evaluation, and medical management. Semin Thorac Cardiovasc Surg. 1999;11(1):41-6. 13. Thomas CE, Mayer SA, Gungor BS, Swarup R, Webster EA, Chang I, et al. Myasthenic crisis: clinical features, mortality, complications, and risks factors for prolonged intubation. Neurology. 1997;48(5):1253-60. 14. Keesey JC. “Crisis” in myasthenia gravis: an historical perspective. Muscle Nerve 2002;26(1):1-3. 15. Snead OC 3rd, Benton JW, Dwyer D, Morley BJ, Kemp GE, Bradley RJ, et al. Juvenile myasthenia gravis. Neurology. 1980;30(7 Pt 1):732-9. 16. Evoli A, Batocchi AP, Bartoccioni E, Lino MM, Minisci C, Tonali P. Juvenile myasthenia gravis with prepubertal onset. Neuromusc Dis. 1998;8(8):561-7. 17. Lindner A, Schalke B, Toyca KV. Outcome in juvenile-onset myasthenia gravis: a retrospective study with long-term follow-up of 79 patients. J Neurol. 1997;244(8):515-20. 18. Selcen D, Dabrowski ED, Michon AM, Nigro MA. High-dose intravenous immunoglobulin therapy in juvenile myasthenia gravis. Pediatr Neurol. 2000;22(1):40-3. 19. Batocchi AP, Majolini L, Evoli A, Lino MM, Minisci C, Tonali P. Course and treatment of myasthenia gravis during pregnancy. Neurology. 1999;52(3):447-52. 20. Plauché WC. Myasthenia gravis in mothers and their newborns. Clin Obstet Gynecol. 1991;34(1):82-99. 21. Tagher RJ, Baumann R, Desai N. Failure of intravenously administered immunoglobulin in the treatment of neonatal myasthenia gravis. J Pediatr 1999;134(2):233-5. 22. Lavrnic D, Losen M, Vujic A, De Baets M, Hajdukovic LJ, Stojanovic V, et al. The features of myasthenia gravis with autoantibodies to MuSK. J Neurol Neurosurg Psychiatry. 2005;76(8):1099-102. 23. Krucylak PE, Naunheim KS. Preoperative preparation and anesthetic management of patients with myasthenia gravis. Semin Thorec Cardiovasc Surg. 1999;11(1):47-53. 24. de José Maria B, Carrero E, Sala X. Myasthenia gravis and regional anaesthesia. Can J Anaesth. 1995;42(2):178-9. 25. Boneva N, Brenner T, Argov Z. Gabapentin may be hazardous in myasthenia gravis. Muscle Nerve. 2000;23(8):1204-8. 26. Lindberg C, Andersen O, Lefvert AK. Treatment of myasthenia gravis with methylprednisolone pulse: a double blind study. Acta Neurol Scand. 1998:97:370-3. 27. Palace J, Newsom-Davis J, Lecky B. A randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis. Neurology. 1998;50(6):1778-83. 28. Warmolts JR, Engel WK. Benefit from alternate-day prednisone in myasthenia gravis. N Engl J Med. 1972;286(1):17-20. 29. Evoli A, Batocchi AP, Palmisani MT, Lo Monaco ML, Tonali P. Long-term results of corticosteroid therapy in patients with myasthenia gravis. Eur Neurol. 1992;32(1):37-43. 474